Imageens

THE FUTURE OF MEDICINE IS PREDICTIVE & PREVENTATIVE

predictive MDR CE class 2a medical device for preventive cardiovascular medicine

IMAGEENS has developed Europe’s first clinically-validated software as a medical device enabling the measurement of biomarkers linked to patients’ cardiovascular risk and cardiovascular aging. Our software as a medical device has successfully received the notoriously challenging class 2a approval under the EU’s new Medical Device Regulation (EU MDR).

ArtFun+

Enabling the measurement of predictive biomarkers 

linked to cardiovascular risk & aging

Based on a robust, clinically 
validated platform

We share our knowledge & approach with leading healthcare institutions to build more Predictive Clinical Decision AI

Our mission is to help physicians make better clinical decisions for their patients by making the most of their imaging data. By working with leading healthcare institutions, we:

1

MEASURE PREDICTIVE BIOMARKERS

Precisely characterise patients’ cardiovascular system, to help inform clinical decisions and evaluate drugs’ efficacy

2

CREATE STRUCTURED IMAGING DATABASES FOR AI-TRAINING

Clean & prepare our partners’ databases to make them ready for AI-training

3

BUILD CLINICAL DECISION AI

Using our biomarkers & the structured data, build AI clinical decision tools to predict patients’ outcomes and improve clinical decisions

Label

Preparing large imaging
datasets for AI-training

We partner with

We’ve been awarded by

Check out our news

March 31, 2021

 
L’AP-HP et IMAGEENS créent un modèle de collaboration pour la structuration et la valorisation des données du soin

April 14, 2021

Imageen raises
Euro 1.2 million
to ramp up
launch its first AI products

MAY 12, 2020

Why AI
won’t replace
doctors